Literature DB >> 7621597

Proteolysis of classic anti-neutrophil cytoplasmic autoantibodies (C-ANCA) by neutrophil proteinase 3.

K M Dolman1, A Jager, A Sonnenberg, A E von dem Borne, R Goldschmeding.   

Abstract

C-ANCA, which are directed against neutrophil proteinase 3 (PR3), are specific markers for the diagnosis of active Wegener's granulomatosis (WG). The correlation between C-ANCA titre and WG disease activity suggests that these autoantibodies are involved in the development of WG. We have previously observed that C-ANCA interfere with PR3 proteolytic activity and with complexation of PR3 with its major physiologic inhibitor alpha 1-antitrypsin (alpha 1-AT). The possible pathogenic importance of C-ANCA may be related to the stability of C-ANCA IgG-PR3 complexes. In the present study we tested proteolysis by PR3 of human IgG and proteolysis of C-ANCA IgG complexed to the enzyme. All human IgG subclass proteins were cleaved by PR3. Digestion products were compared with those obtained by human neutrophil elastase (HNE)-mediated proteolysis of human IgG subclass proteins. Although cleavage products of similar size could be identified, the proteolytic activity of both enzymes towards human IgG differed. Furthermore, inhibiting C-ANCA IgG were cleaved into small peptides when complexed to PR3. The possible pathogenic consequences of these findings will be discussed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7621597      PMCID: PMC1553284          DOI: 10.1111/j.1365-2249.1995.tb02269.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  24 in total

1.  Association between active Wegener's granulomatosis and anticytoplasmic antibodies.

Authors:  J W Tervaert; F J van der Woude; A S Fauci; J L Ambrus; J Velosa; W F Keane; S Meijer; M van der Giessen; G K van der Hem; T H The
Journal:  Arch Intern Med       Date:  1989-11

2.  Specificity of anti-neutrophil cytoplasmic autoantibodies for proteinase 3.

Authors:  J C Jennette; J R Hoidal; R J Falk
Journal:  Blood       Date:  1990-06-01       Impact factor: 22.113

3.  Azurocidin and a homologous serine protease from neutrophils. Differential antimicrobial and proteolytic properties.

Authors:  D Campanelli; P A Detmers; C F Nathan; J E Gabay
Journal:  J Clin Invest       Date:  1990-03       Impact factor: 14.808

4.  Antibiotic proteins of human polymorphonuclear leukocytes.

Authors:  J E Gabay; R W Scott; D Campanelli; J Griffith; C Wilde; M N Marra; M Seeger; C F Nathan
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

5.  Proteinase 3. A distinct human polymorphonuclear leukocyte proteinase that produces emphysema in hamsters.

Authors:  R C Kao; N G Wehner; K M Skubitz; B H Gray; J R Hoidal
Journal:  J Clin Invest       Date:  1988-12       Impact factor: 14.808

6.  Wegener's granulomatosis autoantigen is a novel neutrophil serine proteinase.

Authors:  J L Niles; R T McCluskey; M F Ahmad; M A Arnaout
Journal:  Blood       Date:  1989-11-01       Impact factor: 22.113

7.  Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro.

Authors:  R J Falk; R S Terrell; L A Charles; J C Jennette
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

8.  Wegener's granulomatosis autoantibodies identify a novel diisopropylfluorophosphate-binding protein in the lysosomes of normal human neutrophils.

Authors:  R Goldschmeding; C E van der Schoot; D ten Bokkel Huinink; C E Hack; M E van den Ende; C G Kallenberg; A E von dem Borne
Journal:  J Clin Invest       Date:  1989-11       Impact factor: 14.808

9.  Anti-neutrophil cytoplasm antibodies in Wegener's granulomatosis recognize an elastinolytic enzyme.

Authors:  J Lüdemann; B Utecht; W L Gross
Journal:  J Exp Med       Date:  1990-01-01       Impact factor: 14.307

10.  The human neutrophil serine proteinases, elastase and cathepsin G, can mediate glomerular injury in vivo.

Authors:  R J Johnson; W G Couser; C E Alpers; M Vissers; M Schulze; S J Klebanoff
Journal:  J Exp Med       Date:  1988-09-01       Impact factor: 14.307

View more
  9 in total

1.  Proteinase 3 contributes to transendothelial migration of NB1-positive neutrophils.

Authors:  Christopher J Kuckleburg; Sarah B Tilkens; Sentot Santoso; Peter J Newman
Journal:  J Immunol       Date:  2012-01-20       Impact factor: 5.422

2.  Characterization of monoclonal antibodies to proteinase 3 (PR3) as candidate tools for epitope mapping of human anti-PR3 autoantibodies.

Authors:  Y M Van Der Geld; P C Limburg; C G Kallenberg
Journal:  Clin Exp Immunol       Date:  1999-12       Impact factor: 4.330

3.  Alternative complement pathway induction by ANCA.

Authors:  Hans U Lutz
Journal:  Am J Pathol       Date:  2008-08-07       Impact factor: 4.307

4.  Membrane-Associated Proteinase 3 on Granulocytes and Acute Myeloid Leukemia Inhibits T Cell Proliferation.

Authors:  Tian-Hui Yang; Lisa S St John; Haven R Garber; Celine Kerros; Kathryn E Ruisaard; Karen Clise-Dwyer; Gheath Alatrash; Qing Ma; Jeffrey J Molldrem
Journal:  J Immunol       Date:  2018-07-18       Impact factor: 5.422

5.  Agreement of anti-neutrophil cytoplasmic antibody measurements obtained from serum and plasma.

Authors:  A S Lee; J D Finkielman; T Peikert; A M Hummel; M A Viss; G L Jacob; H A Homburger; U Specks
Journal:  Clin Exp Immunol       Date:  2006-10       Impact factor: 4.330

Review 6.  B cell epitope specificity in ANCA-associated vasculitis: does it matter?

Authors:  Y M van der Geld; C A Stegeman; C G M Kallenberg
Journal:  Clin Exp Immunol       Date:  2004-09       Impact factor: 4.330

7.  Proteinase 3 Induces Neuronal Cell Death Through Microglial Activation.

Authors:  Kyu Suk Cho; Eun Joo Lee; Jung Nam Kim; Ji Woong Choi; Hahn Young Kim; Seol-Heui Han; Jong Hoon Ryu; Jae Hoon Cheong; Chan Young Shin; Kyoung Ja Kwon
Journal:  Neurochem Res       Date:  2015-09-08       Impact factor: 3.996

8.  Interference of PR3-ANCA with the enzymatic activity of PR3: differences in patients during active disease or remission of Wegener's granulomatosis.

Authors:  Y M van der Geld; A T J Tool; J Videler; M de Haas; J W Cohen Tervaert; C A Stegeman; P C Limburg; C G M Kallenberg; D Roos
Journal:  Clin Exp Immunol       Date:  2002-09       Impact factor: 4.330

Review 9.  What you should know about PR3-ANCA. An introduction.

Authors:  A Wiik
Journal:  Arthritis Res       Date:  2000-06-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.